“How do you maintain human skin alive so that you can generate data from what would otherwise be trash?” asked Eric Merle, chief business innovation officer of Salem, Massachusetts–based Genoskin. “We work with surgical discards.” Founded a decade ago, Genoskin collects human skins from cosmetic surgeries such as face-lifts and abdominal surgeries that would otherwise…
Insilico Medicine announces PROTAC partnership with Arvinas
Insilico Medicine (Hong Kong) has entered into an R&D pact with Arvinas (NSDQ:ARVN) to explore applications of Insilico’s AI technology to PROTACs. By regulating protein function, PROTACS can optimize the sensitivity to drug-resistant targets, as an article in Signal Transduction and Targeted Therapy notes Insilico and Arvinas will partner in designing treatment modalities for current and next-generation…
How to build a foundation for the next phase of Alzheimer’s disease research
Alzheimer’s disease has one of the highest financial burdens. The Alzheimer’s Association estimates that the cost of the disease in the U.S. will hit $355 billion in 2021. “Not only is Alzheimer’s one of the most expensive, it’s probably one of the most devastating diseases of humans,” said Dr. Allan Levey, professor and chairman of…